Delivery Order SPE2DB22D1017-SPE2DB24FF8SY
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of UBRELVY 50 MG TABLET UD 10S. The contract has a ceiling value of $1,411.72 and a completion date of September 17, 2024. This appears to be a delivery order placed against a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $5,374.60 firm-fixed-price contract is for the delivery of UBRELVY 100 MG TABLET UD 10S, a pharmaceutical product. The contract has an ultimate completion date of December 18, 2023 and was awarded on December 15, 2023. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen holds...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of UBRELVY 100 MG TABLET UD 10S, a pharmaceutical product. The contract is a firm fixed-price delivery order with a ceiling value of $1,146.60 and a period of performance through May 16, 2025. The contract is not set aside and was openly competed. AmerisourceBergen Drug Corp holds...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,072.86, is for the supply of UBRELVY 100 MG TABLET UD 10S, a pharmaceutical product. The contract is a firm fixed-price delivery order, with a completion date of February 5, 2025. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of UBRELVY 100 MG TABLET UD 16S. The contract has a ceiling value of $15,763.76 and a completion date of May 13, 2025. It is not designated as a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of UBRELVY 100 MG TABLET UD 10S. The contract has a firm fixed price of $2,374.54 and a completion date of June 5, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of UBRELVY 100 MG Tablet UD 10S, a pharmaceutical product. The contract has a ceiling value of $21,348.93 and a period of performance through February 13, 2025. It is a firm-fixed-price contract, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of UBRELVY 100 MG TABLET UD 16S, a prescription medication. The contract has a ceiling value of $81,598.11 and is a firm-fixed-price delivery order with a period of performance through June 24, 2025. The contract is not set-aside and was awarded on an open competitive basis....
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,389.66, is for the delivery of UBRELVY 100 MG TABLET UD 10S, a pharmaceutical product. The contract is a firm fixed-price agreement with a completion date of November 16, 2023. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of UBRELVY 100 MG TABLET UD 16S, a pharmaceutical product. The contract has a ceiling value of $22,799.13 and is a firm fixed price, non-set-aside contract. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB24FF8SYDelivery Order
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of UBRELVY 100 MG TABLET UD 10S, a pharmaceutical product, with a total ceiling value of $3,206.81. The contract has an ultimate completion date of June 3, 2024. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating that it was awarded through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 5/31/24 |